Psychiatry · Massapequa, NY
NPI
1699087148
Since 2010
Specialty
Psychiatry
Code 2084P0800X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
5550 Merrick Rd Ste 300
Massapequa, NY, 11758
Phone (631) 673-3233
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
13,947 services
Medicare patients, 2024
785
Average age 66
Drug cost, 2024
$870K
5,068 prescriptions
Company payments, 2025
$82K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Priyadarshan Bajpayi was code 99214 (office e&m - established), 3,837 times for 590 patients. In total Priyadarshan Bajpayi billed 13,947 services in 20 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,837 | 590 | $79.18 | $304K |
| 90836 Psychotherapy - Nongroup | Office | 2,874 | 445 | $62.78 | $180K |
| 90833 Psychotherapy - Nongroup | Office | 1,933 | 407 | $48.18 | $93K |
| 90837 Psychotherapy - Nongroup | Office | 1,617 | 123 | $107.96 | $175K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 1,054 | 13 | $23.66 | $25K |
| 99213 Office E&M - Established | Office | 639 | 178 | $53.79 | $34K |
| 96130 Behavioral Health Services | Office | 529 | 301 | $94.91 | $50K |
| 90868 Treatment - Miscellaneous | Office | 381 | 13 | $155.23 | $59K |
| 99215 Office E&M - Established | Office | 335 | 30 | $130.33 | $44K |
| 90792 Psychotherapy - Nongroup | Office | 295 | 294 | $144.64 | $43K |
| 80305 Drug Tests | Office | 282 | 277 | $12.27 | $3,459 |
| 90834 Psychotherapy - Nongroup | Office | 80 | 18 | $73.88 | $5,911 |
| 99212 Office E&M - Established | Office | 31 | 21 | $30.59 | $948 |
By year: 2022 $642K for 6,452 services; 2023 $769K for 9,016 services; 2024 $1.0M for 13,947 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 282 | 277 | $12.27 | $3,459 |
Medicare prescription drug claims, 2024
In 2024, the drug Priyadarshan Bajpayi prescribed most often to Medicare patients was Clonazepam, with 488 prescriptions and refills. In total Priyadarshan Bajpayi wrote 5,068 Medicare prescriptions that cost $870K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 488 | 494 | 73 | $3,717 |
| Alprazolam Generic | 384 | 384 | 60 | $2,028 |
| Lamotrigine Generic | 310 | 445 | 57 | $2,485 |
| Zolpidem Tartrate Generic | 230 | 230 | 32 | $3,626 |
| Olanzapine Generic | 184 | 260 | 34 | $3,530 |
| Quetiapine Fumarate Generic | 176 | 323 | 35 | $1,605 |
| Bupropion Xl Bupropion Hcl | 169 | 267 | 33 | $2,296 |
| Fluoxetine Hcl Generic | 167 | 276 | 33 | $721 |
| Trazodone Hcl Generic | 148 | 249 | 34 | $1,867 |
| Spravato Esketamine Hcl | 131 | 131 | 13 | $252K |
| Escitalopram Oxalate Generic | 131 | 245 | 34 | $1,240 |
| Aripiprazole Generic | 130 | 186 | 27 | $3,258 |
| Sertraline Hcl Generic | 124 | 208 | 24 | $641 |
| Diazepam Generic | 124 | 124 | 20 | $1,107 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 114 | 186 | 22 | $1,242 |
Brand drugs: 445 claims; generic drugs: 4,623 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Priyadarshan Bajpayi $82K ($82K in general payments such as food, travel and fees) from 24 companies. The largest payer was Alkermes, Inc. with $27K.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 47 | $27K |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 49 | $20K |
| Janssen Pharmaceuticals, Inc JNJ | 33 | $16K |
| Axsome Therapeutics, Inc. AXSM | 15 | $10K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 23 | $5,123 |
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $510 |
| Abbvie Inc. ABBV | 22 | $500 |
| Teva Pharmaceuticals USA, Inc. TEVA | 21 | $390 |
| Lundbeck LLC | 20 | $365 |
| Neurocrine BioSciences, Inc. NBIX | 10 | $231 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.